Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $145.29 million. The enterprise value is $155.01 million.
| Market Cap | 145.29M |
| Enterprise Value | 155.01M |
Important Dates
The next confirmed earnings date is Friday, November 8, 2024, before market open.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.62 million shares outstanding. The number of shares has increased by 2.17% in one year.
| Shares Outstanding | 16.62M |
| Shares Change (YoY) | +2.17% |
| Shares Change (QoQ) | +1.86% |
| Owned by Insiders (%) | 35.99% |
| Owned by Institutions (%) | 40.08% |
| Float | 10.64M |
Valuation Ratios
The trailing PE ratio is 14.55 and the forward PE ratio is 10.66.
| PE Ratio | 14.55 |
| Forward PE | 10.66 |
| PS Ratio | 0.85 |
| Forward PS | 1.61 |
| PB Ratio | 1.09 |
| P/FCF Ratio | 17.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.76, with an EV/FCF ratio of 19.10.
| EV / Earnings | 15.40 |
| EV / Sales | 0.92 |
| EV / EBITDA | 8.76 |
| EV / EBIT | 11.26 |
| EV / FCF | 19.10 |
Financial Position
The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.12.
| Current Ratio | 4.07 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.86 |
| Debt / FCF | 2.01 |
| Interest Coverage | 6.59 |
Financial Efficiency
Return on equity (ROE) is 7.94% and return on invested capital (ROIC) is 5.81%.
| Return on Equity (ROE) | 7.94% |
| Return on Assets (ROA) | 4.98% |
| Return on Capital (ROIC) | 5.81% |
| Revenue Per Employee | $315,198 |
| Profits Per Employee | $18,774 |
| Employee Count | 536 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 2.85 |
Taxes
In the past 12 months, Ultralife has paid $2.27 million in taxes.
| Income Tax | 2.27M |
| Effective Tax Rate | 18.39% |
Stock Price Statistics
The stock price has increased by +22.24% in the last 52 weeks. The beta is 0.97, so Ultralife's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +22.24% |
| 50-Day Moving Average | 9.47 |
| 200-Day Moving Average | 9.78 |
| Relative Strength Index (RSI) | 41.50 |
| Average Volume (20 Days) | 47,925 |
Short Selling Information
The latest short interest is 174,427, so 1.05% of the outstanding shares have been sold short.
| Short Interest | 174,427 |
| Short Previous Month | 197,470 |
| Short % of Shares Out | 1.05% |
| Short % of Float | 1.64% |
| Short Ratio (days to cover) | 2.39 |
Income Statement
In the last 12 months, Ultralife had revenue of $168.95 million and earned $10.06 million in profits. Earnings per share was $0.60.
| Revenue | 168.95M |
| Gross Profit | 44.21M |
| Operating Income | 13.76M |
| Pretax Income | 12.33M |
| Net Income | 10.06M |
| EBITDA | 17.70M |
| EBIT | 13.76M |
| Earnings Per Share (EPS) | $0.60 |
Balance Sheet
The company has $6.69 million in cash and $16.28 million in debt, giving a net cash position of -$9.59 million or -$0.58 per share.
| Cash & Cash Equivalents | 6.69M |
| Total Debt | 16.28M |
| Net Cash | -9.59M |
| Net Cash Per Share | -$0.58 |
| Equity (Book Value) | 133.35M |
| Book Value Per Share | 8.01 |
| Working Capital | 63.21M |
Cash Flow
In the last 12 months, operating cash flow was $10.39 million and capital expenditures -$2.27 million, giving a free cash flow of $8.12 million.
| Operating Cash Flow | 10.39M |
| Capital Expenditures | -2.27M |
| Free Cash Flow | 8.12M |
| FCF Per Share | $0.49 |
Margins
Gross margin is 26.17%, with operating and profit margins of 8.15% and 5.96%.
| Gross Margin | 26.17% |
| Operating Margin | 8.15% |
| Pretax Margin | 7.29% |
| Profit Margin | 5.96% |
| EBITDA Margin | 10.48% |
| EBIT Margin | 8.15% |
| FCF Margin | 4.80% |
Dividends & Yields
Ultralife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.17% |
| Shareholder Yield | -2.17% |
| Earnings Yield | 6.93% |
| FCF Yield | 5.59% |
Analyst Forecast
The average price target for Ultralife is $14.00, which is 60.18% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 60.18% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ultralife has an Altman Z-Score of 3.77 and a Piotroski F-Score of 8.
| Altman Z-Score | 3.77 |
| Piotroski F-Score | 8 |